Exploring the Biological Effects of Anti-Diabetic Vanadium Compounds in the Liver, Heart and Brain
Yalka Dayanand,Reveshni Pather,Nombuso Xulu,Irvin Booysen,Ntethelelo Sibiya,Andile Khathi,Phikelelani Ngubane
DOI: https://doi.org/10.2147/dmso.s417700
2024-09-04
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yalka Dayanand, 1 Reveshni Pather, 1 Nombuso Xulu, 1 Irvin Booysen, 2 Ntethelelo Sibiya, 3 Andile Khathi, 1 Phikelelani Ngubane 1 1 School of Laboratory Medicine and Medical Science, University of Kwazulu-Natal, Durban, South Africa; 2 School of Chemistry and Physics, University of Kwazulu-Natal, Pietermaritzburg, South Africa; 3 Pharmacology Division, Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa Correspondence: Reveshni Pather, Department of Human Physiology School of Laboratory Medicine and Medical Sciences College of Health Sciences, University of KwaZulu-Natal, E-Block, Level 4, University Road, Chiltern Hills, Westville Campus, Private Bag X54001, Westville, Durban, 4000, South Africa, Tel +27826570642, Email The prevalence of diabetes mellitus and diabetes-related complications is rapidly increasing worldwide, placing a substantial financial burden on healthcare systems. Approximately 537 million adults are currently diagnosed with type 1 or type 2 diabetes globally. However, interestingly, the increasing morbidity rate is primarily influenced by the effects of long-term hyperglycemia on vital organs such as the brain, the liver and the heart rather than the ability of the body to use glucose effectively. This can be attributed to the summation of the detrimental effects of excessive glucose on major vascular systems and the harmful side effects attributed to the current treatment associated with managing the disease. These drugs have been implicated in the onset and progression of cardiovascular disease, hepatocyte injury and cognitive dysfunction, thereby warranting extensive research into alternative treatment strategies. Literature has shown significant progress in utilizing metal-based compounds, specifically those containing transition metals such as zinc, magnesium and vanadium, in managing hyperglycaemia. Amongst these metals, research carried out on vanadium reflected the most promising anti-diabetic efficacy in cell culture and animal studies. This was attributed to the ability to improve glucose management in the bloodstream by enhancing its uptake and metabolism in the kidney, brain, skeletal muscle, heart and liver. Despite this, organic vanadium was considered toxic due to its accumulative characteristics. To alleviate vanadium's toxic nature while subsequently manipulating its therapeutic properties, vanadium complexes were synthesized using either vanadate or vanadyl as a base compound. This review attempts to evaluate organic vanadium salts' therapeutic and toxic effects, highlight vanadium complexes' research and provide insight into the novel dioxidovanadium complex synthesized in our laboratory to alleviate hyperglycaemia-associated macrovascular complications in the brain, heart and liver. Keywords: diabetes mellitus, hyperglycaemia, dioxidovanadium, toxicity The prevalence of diabetes mellitus (DM) poses a significant challenge to global health. 1 Despite the generation of new pharmaceuticals and the advancement of clinical treatment, diabetes is becoming increasingly prevalent. 1 Approximately 537 million people are diagnosed with type 1 or type 2 diabetes globally, with drastic predicted increases in middle and low-income countries. 2,3 DM accounts for approximately 8.5% of worldwide mortality rates, and 20% of mortalities result from multiple micro and macrovascular organ systems dysfunctions. 3,4 However, this review will focus on the ramifications of diabetes and current treatment strategies on the organ systems, viz., the brain, liver and heart, which possess large blood vessels, and the effects of vanadium compounds on them. 2,5 Hyperglycaemia induced injury to vasculature in organs such as the liver, heart and brain has been shown to result in the formation of atherosclerotic plaques in these blood vessels, resulting in cardiovascular disease, stroke, or organ failure. 6–8 Current DM treatment involves using four main classes of drugs; however, insulin remains the mainstay treatment. 9,10 However, these pharmacological drugs have several detrimental side effects. These drugs are known to be involved in the progression of heart disease, hepatocyte injury and brain dysfunction, contributing to the high morbidity and mortality rates. 11,12 Research into alternative treatment strategies is warranted. Literature has shown significant progress in utilizing metal-based compounds, specifically those containing transition metals such as zinc, magnesium and vanadium, in managing hyperglycaemia. 13 Vanadium's insulin-mimicking ability to increase insulin sensitivity, enhanced cellular glucose transport, and glycogen synthesis have made it the most extensively researc -Abstract Truncated-
endocrinology & metabolism